We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
BioNeutra Global Corporation | TSXV:BGA | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.03 | 0.03 | 0.10 | 0 | 13:35:50 |
RNS Number:4897N Dr. Anthony Mullins 11 July 2003 Dr. Anthony Mullins 11 July 2003 Re : Approach to Barlo Group plc Dr Anthony Mullins notes today's announcement by Barlo Group plc ('Barlo' or the 'Company') concerning his approach to the Company on behalf of himself and members of the Barlo management team. He confirms that his approach, which may or may not lead to an offer, was made on the basis of an offer price of Euro30 cent for each Barlo share. This matter is at a very early stage and there can be no certainty that an offer will be made arising from this approach. The holder of 1% or more of any relevant securities in Barlo may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules 2001, from the date of this announcement. Enquiries : Peter Crowley IBI Corporate Finance Ltd Tel : 661 6633 Mark Spain Gerry O'Sullivan Q4 Public Relations Tel : 475 1444 Angie Kinane Dr Mullins accepts responsibility for the information contained in this announcement. To the best of his knowledge and belief (having taken all reasonable care to ensure that such is the case) the information contained in this announcement for which he takes responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. IBI Corporate Finance Limited, which is authorised by the Irish Financial Services Regulatory Authority, is acting for Dr Mullins and his team and no one else in connection with the matter referred to in this announcement and will not be responsible to anyone other than Dr Mullins and his team for providing the protections afforded to clients of IBI Corporate Finance Limited nor for providing advice in relation to the matter referred to in this announcement. This announcement has been issued through the Companies Announcement Service of the Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange END ISEGGGMNNMVGFZM
1 Year BioNeutra Global Chart |
1 Month BioNeutra Global Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions